Hallucinogenic Mushrooms Pass First Hurdle for Depression Treatment

Scientists are testing mushrooms to treat diseases such as Alzheimer's, anorexia, obsessive-compulsive disorder, and migraine.

RIO DE JANEIRO, BRAZIL - A drug used at parties is showing evidence of legitimacy: hallucinogenic mushrooms have overcome the first obstacle to conducting the tests needed before the drug can be used as treatment against depression.

Psilocybin, the active ingredient in mushrooms, was considered safe and well-tolerated when administered to healthy volunteers, in a study conducted by researchers at King's College London.

Obviously, the test left the individuals "high".

Companies and researchers have investigated the medical and commercial potential of recreational drugs such as Subscribe to our Premium Membership Plan. Already Subscribed?